Pfizer Shares Advance On "Encouraging" Data From Once-Daily Weight Loss Pill
Pfizer Shares Advance On “Encouraging” Data From Once-Daily Weight Loss Pill Shares of Pfizer Inc. are rising in premarket trading in New York following news that the drugmaker is progressing with its once-daily anti-obesity pill, ‘danuglipron’ in clinical trials. “Pfizer plans to conduct dose optimization studies in the second half of 2024 evaluating multiple doses […]
Discuss on Nostr!
Nostr Note ID note1hlxg9nz9wufkzdszht93777nlgjehqsly822erg4zu2wjwaxjgnqnzssmj Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.